Canada Markets open in 4 hrs 28 mins

LexaGene Holdings Inc. (LXG.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.2200-0.0050 (-2.22%)
At close: 02:04PM EST
Full screen
Previous Close0.2250
Open0.2400
Bid0.2200 x 0
Ask0.2300 x 0
Day's Range0.2200 - 0.2400
52 Week Range0.0650 - 0.3800
Volume22,550
Avg. Volume48,152
Market Cap30.941M
Beta (5Y Monthly)1.49
PE Ratio (TTM)N/A
EPS (TTM)-0.1170
Earnings DateJun 28, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.50
  • GlobeNewswire

    LexaGene’s MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma Customers

    BEVERLY, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLabTM System for automated, genetic testing, is pleased to announce exciting news regarding the ability of the MiQLab System to detect Mycoplasma at minute levels. Dr. Jack Regan, CEO and Founder of LexaGene commented, “In the process of completing the follow-on feasibility study with one o

  • GlobeNewswire

    BioPharma Engages LexaGene in Second Feasibility Study

    Cancels Plans to Reprice Meridian’s WarrantsBEVERLY, Mass. , Dec. 16, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic testing, is pleased to announce the large biopharma company (>$100B Market Cap) that previously purchased a MiQLab System has engaged LexaGene in a second statement of work (“SOW”) that builds off of the previou

  • GlobeNewswire

    LexaGene Holdings Proposes to Amend Warrants Terms

    BEVERLY, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, genetic testing, announces that it intends to amend the exercise price of certain common share purchase warrants (the “Warrants”) originally issued on February 7 and February 18, 2022 to Meridian LGH Holdings, LLC and expiry five years after the date of issue. An